Coloplast A/S (CLPBF)
OTCMKTS · Delayed Price · Currency is USD
96.80
+0.20 (0.21%)
Aug 29, 2025, 9:31 AM EDT
Coloplast Revenue
Coloplast had revenue of 6.96B DKK in the quarter ending June 30, 2025, with 1.06% growth. This brings the company's revenue in the last twelve months to 27.87B, up 5.95% year-over-year. In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B with 10.33% growth.
Revenue (ttm)
27.87B DKK
Revenue Growth
+5.95%
P/S Ratio
4.93
Revenue / Employee
1.67M DKK
Employees
16,639
Market Cap
21.63B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |
Coloplast News
- 13 days ago - Coloplast A/S (CLPBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Coloplast A/S - Interim Financial Report, 9M 2024/25 - GlobeNewsWire
- 13 days ago - Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025 - GlobeNewsWire
- 13 days ago - Coloplast A/S Non-GAAP EPS of DKK 3.86, revenue of DKK 6.96B; reaffirms FY outlook - Seeking Alpha
- 13 days ago - Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team - GlobeNewsWire
- 18 days ago - Coloplast: Despite The Drawdown, Still Not A Buy - Seeking Alpha
- 24 days ago - Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST - GlobeNewsWire
- 4 weeks ago - Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What's Fueling the Surge? | MarketsandMarkets™. - Benzinga